BackRepliCel Life Sciences Overview

RepliCel Life Sciences Inventory

Latest inventory for REPCF: $-7.7K.

Get informed when a big investor buys or sells

+ Follow
Inventory
$-7695.00

Peer trimmed avg / median

Loading

RepliCel Life Sciences Inventory History

Loading

RepliCel Life Sciences vs. peers: Inventory Comparison

Loading

RepliCel Life Sciences Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RepliCel Life Sciences (REPCF) FAQ

The latest inventory for REPCF is $-7.7K as of June 2024. In the prior-year period, the figure was $0. Investors often review this figure alongside RepliCel Life Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, REPCF's inventory moved from $0 to $-7.7K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RepliCel Life Sciences's operating scale or balance-sheet position.

A inventory figure of $-7.7K for REPCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REPCF's inventory ($-7.7K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack RepliCel Life Sciences's inventory against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.